NCT03085290View on ClinicalTrials.gov

Allogeneic Versus Autologous Serum Eye Drops

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

October 8, 2018

Study Completion Date

October 8, 2018

Conditions
Dry Eye Syndrome
Interventions
OTHER

Autologous serum eye drops

Autologous serum eye drop doses will be 6 times daily in each eye

OTHER

Allogeneic serum eye drops

Allogeneic serum eye drop doses will be 6 times daily in each eye

Trial Locations (1)

Unknown

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Sanquin Research & Blood Bank Divisions

OTHER

NCT03085290 - Allogeneic Versus Autologous Serum Eye Drops | Biotech Hunter | Biotech Hunter